Last Update 07 Dec 25

NTR: Portfolio Streamlining And Farm Headwinds Will Shape Balanced Returns Ahead

Analysts have modestly reduced their price expectations for Nutrien, trimming the target by a low single digit dollar amount to reflect a tougher near term farm income backdrop, portfolio streamlining impacts, and a more balanced risk reward view despite solid recent execution.

Analyst Commentary

Street research on Nutrien reflects a constructive long term view, tempered by nearer term caution around farm fundamentals, commodity pricing and the impact of recent portfolio moves.

Bullish Takeaways

Bullish analysts continue to view Nutrien as a top pick in the fertilizers and chemicals space, citing its solid Q3 balance sheet and resilient earnings power as support for premium valuation versus peers.
Despite modest target trims, several ratings remain in the Outperform range. This underscores confidence that Nutrien can execute on strategic initiatives and drive upside as fertilizer markets normalize.
The portfolio streamlining program, including recent asset sales, is seen as improving focus and capital allocation. There is potential for multiple expansion as the business mix becomes cleaner.
Fertilizers are viewed by some as having the greatest potential to positively surprise within the broader agriculture complex. This provides an embedded call option on a turn in the ag cycle.

Bearish Takeaways

Bearish analysts emphasize a more balanced risk reward profile following the stock's strong year to date performance. They argue that current valuation already discounts much of the recovery in fertilizer pricing.
Target price reductions, even if modest, reflect concerns around a difficult near term setup for farmers. These include record North American harvests, weaker crop prices, and a tepid end market demand backdrop.
Some see the fertilizer price rally as losing steam, with persistent worries about the agriculture cycle limiting the scope for further multiple expansion from roughly mid single digit EBITDA valuations.
Portfolio actions such as the removal of Trinidad exposure and South American asset sales are viewed as marginally dilutive to near term earnings. This contributes to cautious positioning on growth expectations.

What's in the News

The U.S. Department of Agriculture and Department of Justice launch a joint antitrust investigation into suppliers of crop inputs, including fertilizers, pressuring shares of major players such as Nutrien (Bloomberg).
Nutrien updates its 2025 operating guidance, modestly raising expected potash sales volumes and fine tuning nitrogen volume expectations while keeping phosphate guidance unchanged.
The company confirms it remains on track to deliver its 2025 nitrogen sales volume guidance of 10.7 million tonnes to 11.2 million tonnes, supported by strong performance in North American nitrogen operations.
Nutrien begins a controlled shutdown of its Trinidad nitrogen operations at the Point Lisas facility effective October 23, 2025, citing port access restrictions and inadequate, uneconomic natural gas supply, while still expecting to meet 2025 nitrogen volume targets from North America.
Under its current share repurchase program announced in February 2025, Nutrien has completed the buyback of 9.27 million shares, or 1.9 percent of shares outstanding, for a total of approximately CAD 519 million.

Valuation Changes

Fair Value: Unchanged at CA$88.43 per share, indicating no revision to the modelled long term intrinsic value.
Discount Rate: Reduced slightly from 7.33 percent to 7.26 percent, reflecting a marginally lower perceived risk profile or funding cost.
Revenue Growth: Trimmed modestly from 2.88 percent to 2.55 percent, suggesting a slightly more cautious outlook on top line expansion.
Net Profit Margin: Lowered marginally from 7.53 percent to 7.34 percent, pointing to a small expected compression in profitability.
Future P/E: Increased moderately from 17.19x to 18.10x, signalling a somewhat higher valuation multiple applied to forward earnings.

Strong global food demand and adoption of advanced agriculture practices are driving steady growth, higher-margin sales, and improved revenue stability for Nutrien.
Operational efficiencies, cost reductions, and disciplined capital allocation are enhancing margins, free cash flow, and shareholder returns over the long term.
Regulatory pressures, shifting agricultural practices, market dependency, execution risks, and lack of diversification threaten Nutrien's profitability, revenue growth, and future market position.

Catalysts

About Nutrien

Provides crop inputs and services.What are the underlying business or industry changes driving this perspective?

Global food demand is structurally supporting long-term fertilizer use: Increasing world population and rising global food demand, particularly in emerging markets, are creating sustained demand for essential crop nutrients like potash and nitrogen-Nutrien's core products-which should underpin stable or growing sales volumes and improve revenue visibility.
Adoption of yield-maximizing and resource-optimizing ag practices: The drive to maximize yields per acre due to climate change, shrinking arable land, and erratic weather is boosting fertilizer adoption and incentivizing precision agriculture. Nutrien's investments in automation, precision ag, and efficiency position it to capture higher-margin, premium sales and expand net margins over time.
Tight industry supply and high operating efficiency: Supply-side constraints, slow addition of new global capacity, and strengthening fertilizer fundamentals have resulted in rising prices and reduced competitive threats, while Nutrien's mine automation and debottlenecking initiatives are lowering per-ton production costs, supporting both top-line growth and margin expansion.
Operational cost reductions and portfolio optimization: Ongoing SG&A and capex reductions, accelerated cost savings programs, and modernization of distribution structures (especially in Brazil and North America) are already increasing adjusted EBITDA and will structurally enhance net margins and free cash flow generation into 2026.
Enhanced shareholder returns and disciplined capital allocation: Consistent share buybacks, durable dividend growth, and asset divestitures are directly increasing free cash flow per share and underpin rising earnings per share, signaling management's confidence in long-term earnings growth and balance sheet strength.

Nutrien Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Nutrien's revenue will grow by 3.2% annually over the next 3 years.
Analysts assume that profit margins will increase from 5.4% today to 8.5% in 3 years time.
Analysts expect earnings to reach $2.3 billion (and earnings per share of $4.87) by about September 2028, up from $1.4 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as $1.6 billion.
In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 15.2x on those 2028 earnings, down from 20.3x today. This future PE is greater than the current PE for the US Chemicals industry at 11.3x.
Analysts expect the number of shares outstanding to decline by 1.53% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 7.22%, as per the Simply Wall St company report.

Nutrien Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?

Increasing regulatory scrutiny and potential tightening of environmental regulations on fertilizer production, especially around greenhouse gas emissions and water usage, could drive higher compliance and operational costs, negatively impacting Nutrien's net margins over the long term.
Advances in regenerative agriculture, organic farming practices, and precision agriculture technologies may reduce reliance on synthetic fertilizers, leading to decreased fertilizer application rates and a potential shrinkage of Nutrien's long-term addressable market, pressuring revenue growth.
Nutrien remains highly dependent on potash and nitrogen products for the majority of its earnings; if global fertilizer prices weaken or if alternative crop nutrition solutions such as biologicals and enhanced efficiency fertilizers gain widespread adoption, Nutrien could experience significant revenue and earnings volatility.
The company's success in cost reduction and margin improvement initiatives in key markets like Brazil is contingent on favorable market conditions; any setbacks in execution or sustained market headwinds could undermine improvements in free cash flow and net margins.
Ongoing consolidation and competitive pressures in the fertilizer and crop input sector may erode Nutrien's pricing power, and failure to sufficiently diversify its product portfolio or geographic exposure-especially outside of North America-could result in stagnant or declining revenue and market share over time.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of CA$86.165 for Nutrien based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of CA$96.39, and the most bearish reporting a price target of just CA$61.11.
In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $27.5 billion, earnings will come to $2.3 billion, and it would be trading on a PE ratio of 15.2x, assuming you use a discount rate of 7.2%.
Given the current share price of CA$78.39, the analyst price target of CA$86.17 is 9.0% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Nutrien?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Shifting Market Trends Will Shape Fertilizer Demand Amid Agricultural Cycle Uncertainty